Protection gaps expected to worsen across all lines of insurance business through 2030, finds Bain & Company
Uncertainty around long-term earnings sustainability, emerging risks, and affordability / access present new challenges for insurers AI-driven industry improvements... Read more.
Smartee Pioneers a New Phase in Orthodontics with Silicon Valley Founder Mode
SHANGHAI, March 30, 2025 /PRNewswire/ — As the clear aligner business enters the second quarter of 2025, it shows a promising growth trend. With increasing... Read more.
Alpayana acquires the Ariana Project with a US$200 million investment plan
LIMA, Peru, March 30, 2025 /CNW/ – Alpayana S.A.C. (“Alpayana”) entered into a binding agreement to acquire 100% of the Ariana Project from Southern... Read more.
Entrepreneur Universe Bright Group Announces Audited Financial Results for Fiscal Year Ended December 31, 2024
XI’AN, China, March 30, 2025 /PRNewswire/ — On March 28, 2025, Entrepreneur Universe Bright Group (“EUBG” or the “Company”),... Read more.
TutorABC Expands Leadership Team to Drive Global Growth in Language Learning and Livestreaming E-Commerce Innovation
TAIPEI, March 30, 2025 /PRNewswire/ — TutorABC, a global leader in online education and live-streaming e-commerce, has appointed George Loup and Maximilian... Read more.
Pudu Robotics Unveils FlashBot Arm: A Semi-Humanoid Embodied AI Service Robot for Commercial Applications
SHENZHEN, China, March 30, 2025 /PRNewswire/ — Pudu Robotics, a global leader in service robotics sector, has officially unveiled FlashBot Arm, an innovative... Read more.
BOC Aviation Orders 50 Boeing 737 MAX Jets to Support Global Airlines
SEATTLE, March 30, 2025 /PRNewswire/ — Boeing and BOC Aviation have announced a new, firm order for 50 737-8 jets, expanding the lessor’s 737 MAX portfolio... Read more.
Li-S Energy collaborates with Kea Aerospace to power high altitude UAV flights
SYDNEY, March 30, 2025 /PRNewswire/ — Li-S Energy (ASX:LIS) (‘Li-S’ or ‘the Company’) has signed a collaboration agreement with Kea... Read more.
Akeso’s 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies
Key Highlights: Global first “immuno + anti-vascular” bispecific antibody approved: ivonescimab for EGFR-TKI resistant nsq-NSCLC. Phase III HARMONi study... Read more.
Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients
GALWAY, Ireland and CHICAGO, March 30, 2025 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking... Read more.